Connect® MM- The Multiple Myeloma Disease Registry
About the study
The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Newly diagnosed with symptomatic MM within 2 months of enrollment in Connect®MM registry
- Age ≥18 years
- Willing and able to provide signed informed consent
- Agrees to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel
EXCLUSION CRITERIA
Exclusion Criteria:
- None
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Multiple Myeloma
Age (in years)
18+
Participants needed
3011
Est. Completion Date
Dec 31, 2024
Treatment type
Observational
Sponsor
Celgene
ClinicalTrials.gov identifier
NCT01081028
Study number
Connect MM
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?